[1]
|
Messina, J.P., et al. (2015) Global Distribution and Prevalence of Hepatitis C Virus Genotypes. Hepatology, 61, 77-87.
https://doi.org/10.1002/hep.27259
|
[2]
|
Chen, Y.S., et al. (2011) A Sero-Epidemiological Study on Hepatitis C in China. Chinese Journal of Epidemiology, 32, 888-891.
|
[3]
|
Marchesini, G., et al. (1999) Association of Nonalcoholic Fatty Liver Disease with Insulin Resistance. The American Journal of Medicine, 107, 450-455. https://doi.org/10.1016/S0002-9343(99)00271-5
|
[4]
|
Mohan, V., et al. (2009) Prevalence of Non-Alcoholic Fatty Liver Disease in Urban South Indians in Relation to Different Grades of Glucose Intolerance and Metabolic Syndrome. Diabetes Research and Clinical Practice, 84, 84-91.
https://doi.org/10.1016/j.diabres.2008.11.039
|
[5]
|
Yeung, L.T., King, S.M. and Roberts, E.A. (2001) Moth-er-to-Infant Transmission of Hepatitis C Virus. Hepatology, 34, 223-229. https://doi.org/10.1053/jhep.2001.25885
|
[6]
|
Ruiz-Extremera, A., et al. (2017) Influence of HLA Class I, HLA Class II and KIRs on Vertical Transmission and Chronicity of Hepatitis C Virus in Children. PLOS ONE, 12, e0172527. https://doi.org/10.1371/journal.pone.0172527
|
[7]
|
Pawlowska, M., et al. (2015) What’s New in Hepatitis C Virus Infections in Children? World Journal of Gastroenterology, 21, 10783-10789. https://doi.org/10.3748/wjg.v21.i38.10783
|
[8]
|
Browning, J.D. and J.D. Horton, J.D. (2004) Molecular Mediators of Hepatic Steatosis and Liver Injury. The Journal of Clinical Investigation, 114, 147-152. https://doi.org/10.1172/JCI200422422
|
[9]
|
Malhi, H. and Gores, G.J. (2008) Molecular Mechanisms of Lipotoxi-city in Nonalcoholic Fatty Liver Disease. Seminars in Liver Disease, 28, 360-369. https://doi.org/10.1055/s-0028-1091980
|
[10]
|
Nydegger, A., et al. (2008) Health-Related Quality of Life in Children with Hepatitis C Acquired in the First Year of Life. Journal of Gastroenterology and Hepatology, 23, 226-230. https://doi.org/10.1111/j.1440-1746.2007.04859.x
|
[11]
|
Pawlowska, M., Sobolewska-Pilarczyk, M. and Do-magalski, K. (2018) Hepatitis C Virus Infection in Children in the Era of Direct-Acting Antiviral. World Journal of Gas-troenterology, 24, 2555-2566.
https://doi.org/10.3748/wjg.v24.i24.2555
|
[12]
|
Murray, K.F., et al. (2018) Safety and Efficacy of Ledipas-vir-Sofosbuvir with or without Ribavirin for Chronic Hepatitis C in Children Ages 6-11. Hepatology, 68, 2158-2166. https://doi.org/10.1002/hep.30123
|
[13]
|
(2018) Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommenda-tions for Testing, Managing, and Treating Hepatitis C Virus Infection. Clinical Infectious Diseases, 67, 1477-1492. https://doi.org/10.1093/cid/ciy585
|
[14]
|
Nwaohiri, A., et al. (2018) Hepatitis C Virus Infection in Children: How Do We Prevent It and How Do We Treat It? Expert Review of Anti-Infective Therapy, 16, 689-694. https://doi.org/10.1080/14787210.2018.1509707
|
[15]
|
魏来, 段钟平, 王贵强. 丙型肝炎防治指南(2019年版) [J]. 实用肝脏病杂志, 2020, 23(1): 33-52.
|
[16]
|
WHO (2016) Global Health Sector Strategy on Viral Hepatitis 2016-2021. World Health Organization, Geneva.
|
[17]
|
Jara, P., et al. (2003) Chronic Hepatitis C Virus Infection in Childhood: Clinical Patterns and Evolution in 224 White Children. Clinical Infectious Diseases, 36, 275-280. https://doi.org/10.1086/345908
|
[18]
|
Hofmeister, M.G., et al. (2019) Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016. Hepatology, 69, 1020-1031. https://doi.org/10.1002/hep.30297
|
[19]
|
Sainz, T., et al. (2020) Longitudinal Evolution of Vertically HIV/HCV-Co-Infected vs HCV-Mono-Infected Children. Journal of Viral Hepatitis, 27, 61-67. https://doi.org/10.1111/jvh.13206
|
[20]
|
Indolfi, G., et al. (2019) Hepatitis C Virus Infection in Children and Ado-lescents. The Lancet Gastroenterology and Hepatology, 4, 477-487. https://doi.org/10.1016/S2468-1253(19)30046-9
|
[21]
|
Indolfi, G., et al. (2015) Histopathology of Hepatitis C in Children, a Systematic Review: Implications for Treatment. Expert Review of Anti-Infective Therapy, 13, 1225-1235. https://doi.org/10.1586/14787210.2015.1070668
|
[22]
|
Modin, L., et al. (2019) Epidemiology and Natural History of Hepatitis C Virus Infection among Children and Young People. Journal of Hepatology, 70, 371-378. https://doi.org/10.1016/j.jhep.2018.11.013
|
[23]
|
Mack, C.L., et al. (2012) NASPGHAN Practice Guidelines: Diag-nosis and Management of Hepatitis C Infection in Infants, Children, and Adolescents. Journal of Pediatric Gastroenter-ology and Nutrition, 54, 838-855.
https://doi.org/10.1097/MPG.0b013e318258328d
|
[24]
|
贺珊, 等. 直接抗病毒药物在儿童丙型病毒性肝炎感染中的应用[J]. 世界最新医学信息文摘, 2019, 19(78): 57-58+60.
|
[25]
|
Balistreri, W.F., et al. (2017) The Safety and Effectiveness of Ledipasvir-Sofosbuvir in Adolescents 12-17 Years Old with Hepatitis C Virus Genotype 1 Infection. Hepatology, 66, 371-378. https://doi.org/10.1002/hep.28995
|
[26]
|
El-Khayat, H.R., et al. (2018) The Effectiveness and Safety of Ledipasvir plus Sofosbuvir in Adolescents with Chronic Hepatitis C Virus Genotype 4 Infection: A Re-al-World Experience. Alimentary Pharmacology & Therapeutics, 47, 838- 844. https://doi.org/10.1111/apt.14502
|
[27]
|
Li, X., et al. (2018) Pharmacokinetics, Safety, and Tolerability of the Di-rect-Acting Hepatitis C Antiviral Sofosbuvir in Healthy Chinese Subjects. Clinical Therapeutics, 40, 1556-1566. https://doi.org/10.1016/j.clinthera.2018.07.018
|
[28]
|
Wyles, D., et al. (2017) Post-Treatment Resistance Analysis of Hepatitis C Virus from Phase II and III Clinical Trials of Ledipasvir/Sofosbuvir. Journal of Hepatology, 66, 703-710. https://doi.org/10.1016/j.jhep.2016.11.022
|
[29]
|
Gane, E.J., et al. (2017) Sofosbuvir-Velpatasvir with Ribavirin for 24 Weeks in Hepatitis C Virus Patients Previously Treated with a Direct-Acting Antiviral Regimen. Hepatology, 66, 1083-1089. https://doi.org/10.1002/hep.29256
|
[30]
|
Statler, V.A. and Espinosa, C. (2020) Management of Hepatitis C in Children and Adolescents. Journal of the Pediatric Infectious Diseases Society, 9, 785-790. https://doi.org/10.1093/jpids/piaa114
|
[31]
|
Clemente, M.G., et al. (2020) Present and Future Management of Viral Hepatitis B and C in Children. Clinics and Research in Hepatology and Gastroenterology, 44, 801-809. https://doi.org/10.1016/j.clinre.2020.02.010
|